or
forgot password

Amino Acid Transport Imaging of Parathyroid Adenomas With Anti-3-[18F]FACBC


N/A
18 Years
N/A
Open (Enrolling)
Both
Parathyroid Disease

Thank you

Trial Information

Amino Acid Transport Imaging of Parathyroid Adenomas With Anti-3-[18F]FACBC


Inclusion Criteria:



1. Patients must be 18 years of age or older.

2. Patients will have biochemical and/or clinical evidence of primary
hyperparathyroidism and be a surgical candidate for definitive parathyroid surgery .

3. Ability to lie still for PET scanning

4. Patients must be able to provide written informed consent

Exclusion Criteria:

1. Age less than 18.

2. Inability to lie still for PET scanning.

3. Cannot provide written informed consent.

4. History of secondary hyperparathyroidism.

5. Positive serum or urine pregnancy test within 24 hours of imaging

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Correlate uptake of anti-3-[18F]FACBC to surgical findings of parathyroid adenomas

Outcome Description:

To evaluate if anti-3-[18F]FACBC can detect parathyroid adenomas.

Outcome Time Frame:

At approximately 1 month post scan (time of surgery and pathologic analysis)

Safety Issue:

No

Principal Investigator

David M Schuster, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Emory University

Authority:

United States: Food and Drug Administration

Study ID:

51415

NCT ID:

NCT01574287

Start Date:

August 2012

Completion Date:

September 2014

Related Keywords:

  • Parathyroid Disease
  • Adenoma
  • Parathyroid Diseases
  • Parathyroid Neoplasms

Name

Location
Emory University Atlanta, Georgia  30322